State CO
Clinical Trials in Colorado
Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.
Top Conditions in Colorado
NCT06435000 N/A
Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Diseas...
Condition
Stargardt
Enrollment
75 pts
Location
United States, Germany, United Kingdom
Sponsor
Splice Bio
NCT04524871 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treat...
Condition
Advanced Liver Cancers
Enrollment
518 pts
Location
United States, China, France
Sponsor
Hoffmann-La Roche
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06765109 Phase 3
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Condition
Non-small Cell Lung Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Nuvalent Inc.
NCT00237315 N/A
Recruiting
Longitudinal Study of Urea Cycle Disorders
Condition
Brain Diseases, Metabolic, Inborn
Enrollment
1,500 pts
Location
United States, Canada, Germany
Sponsor
Andrea Gropman
NCT06697197 Phase 1, Phase 2
Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advan...
Condition
Advanced Solid Tumors
Enrollment
413 pts
Location
United States, Belgium, Denmark
Sponsor
Bristol-Myers Squibb
NCT04655118 Phase 2
Recruiting
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Condition
Myelofibrosis
Enrollment
121 pts
Location
United States, Australia, Belgium
Sponsor
Telios Pharma, Inc.
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.
NCT05830968 N/A
Recruiting
Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Infla...
Condition
Inflammatory Acne Vulgaris
Enrollment
42 pts
Location
United States
Sponsor
InMode MD Ltd.
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT05287568 Phase 1
Recruiting
CC-486 and Venetoclax for Acute Myeloid Leukemia
Condition
AML
Enrollment
35 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06586515 Phase 1
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tum...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
630 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
NCT05863520 N/A
Recruiting
A Comparison of Two School Based Interventions to Manage Anxiety in Autistic Stu...
Condition
Autism Spectrum Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5...
Condition
Advanced Solid Tumor
Enrollment
300 pts
Location
United States, Australia, France
Sponsor
PMV Pharmaceuticals, Inc
NCT07449923 Phase 3
Recruiting
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1...
Condition
Diabetic Macular Edema
Enrollment
240 pts
Location
United States
Sponsor
EyePoint Pharmaceuticals, Inc.
NCT06773962 Phase 2
Recruiting
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's ...
Condition
Parkinson's Disease (PD)
Enrollment
62 pts
Location
United States
Sponsor
TrueBinding, Inc.
NCT06782490 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Parti...
Condition
Multiple Sclerosis Spasticity
Enrollment
200 pts
Location
United States, Australia, Canada
Sponsor
Celgene
NCT05896579 N/A
Recruiting
Right Ventricular Response to Exercise Among Patients With Chronic Obstructive P...
Condition
COPD
Enrollment
60 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07078383 N/A
Recruiting
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Us...
Condition
Aortic Aneurysm
Enrollment
150 pts
Location
United States, Austria, Germany
Sponsor
Vascutek Ltd.
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Condition
Advanced Solid Tumor
Enrollment
140 pts
Location
United States, United Kingdom
Sponsor
Nuvectis Pharma, Inc.
NCT06287346 N/A
Recruiting
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
Condition
Edentulism
Enrollment
652 pts
Location
United States, Spain
Sponsor
CeraRoot SL
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co